	Tumor necrosis factor inhibitors and cardiovascular outcomes in adults with moderate-to-severe plaque psoriasis: a systematic review and meta-analysis. An Bras Dermatol Mesa Rodríguez LF, Zambrano Aristizábal A, Vega Padilla JD. PMID: 42945615 [PubMed - as supplied by publisher]
	Topical Vitamin D Analogs Beyond Psoriasis: Pharmacological Mechanisms, Cutaneous Drug Delivery, and Clinical Evidence. Pharmaceutics Laçej D, Pietrella A, Zoratto N, Lombardi M, Di Meo C, Matricardi P. PMID: 42942780 [PubMed]
	The Skin-Bone Axis in Psoriasis: An Emerging Osteoimmunological Perspective. J Clin Med Saito-Sasaki N, Sawada Y. PMID: 42941578 [PubMed]
	Psoriasis and Bullous Pemphigoid: An Updated Review of Clinical Association, Targeted Therapy Exposures and Therapeutic Implications. Biomolecules Cui S, Zhang B, Li L. PMID: 42939646 [PubMed - indexed for MEDLINE]
	Prospective Study of Efficacy, Safety, and Predictors of Response to Deucravacitinib in Chinese Patients with Moderate-to-Severe Plaque Psoriasis. Psoriasis (Auckl) Dong C, Wang Y, Sun J, Lin JM, Lu X, Zhu J, Lin L, Zhu X, Huang H, Xu J, Wu W, Du J. PMID: 42936288 [PubMed]
	Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence. Diabetes Metab Res Rev Wang J, Zhou X, Chen J, Wang Q, Yi X, Gao P, He J, Yang S, Zhang M, Sun X, Liu L, Li X. PMID: 42935224 [PubMed - indexed for MEDLINE]
	Dupilumab and Psoriasis Risk in Patients With Atopic Dermatitis: A Multicenter Cohort Study. Exp Dermatol Block BR, Mehta J, Tang A, Ungar B, Gulati N. PMID: 42932079 [PubMed - indexed for MEDLINE]
	A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis. Dermatol Ther (Heidelb) Kumar S, Kumar S, Krishna V, Shivhare DP, Prasad PG, Kumar H, Mamidwar S, Pande S, Dhawan A, Patro N, Patel D, Shekar C, Parasramani S, Dogra S, Sonawane D, Patil D, Shaikh A, Pandit S, Ghadge P, Mehta S. PMID: 42932042 [PubMed - as supplied by publisher]
	Immunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort. Vaccines (Basel) Magalhães VO, Ribeiro PDC, Peixoto FMMMC, Biegelmeyer E, Aguiar MF, Kayser C, Souza AWS, Castro CHM, Machado KLLL, Mill JG, de Medeiros Junior NF, Batista DCFA, Fraga RSMD, Espirito Santo TMR, Miyamoto ST, Vieira GSS, Lorencini PZ, Souza BO, Surlo HF, Moulin ACS, Athayde PDS, Macabú MO, Ribeiro SLE, Lima RL, Melo NS, Rebello RT, Dias MMS, Rodrigues JWDS, Telles CMPF, Sartori NS, Lima R, de Rezende RPV, Baptista KL, Gaudio RC, Melo AKG, Silva VBD, Cruz VA, Rêgo J, de Abreu Vieira RMR, Vieira ASR, Kakehasi AM, Tavares ACFMG, Pereira AJA, Azevedo RH, Azevedo VF, Martins-Filho OA, Peruhype-Magalhães V, Sato EI, Xavier RM, Teixeira-Carvalho A, Souza VA, Ferreira GA, Dos Reis-Neto ET, Monticielo OA, Valim V, Pileggi GS, Pinheiro MM. PMID: 42931442 [PubMed]
	Long-Term Changes in Complete Blood Count-Derived Inflammatory Indices During Risankizumab Treatment for Psoriasis: A 208-Week Multicenter Real-World Study. Antibodies (Basel) Balestri R, Pallanch C, Magnano M, Colombini J, Clarizio G, Bardazzi F, Di Lernia V, Satolli F, Ganzetti G, Buligan C, Mazzoletti V, Pacetti L, Odorici G, Borghi A, Saraceno R, Mengarino M, Gisondi P, Girolomoni G, Lacava R, Rech G, Bellinato F. PMID: 42930039 [PubMed]
	Gasdermin B and Interleukin-17 Gene Expression in Psoriasis Vulgaris: A Case-Control Study. Indian Dermatol Online J Ghanem MMM, Hammam MA, El Derbaly SA, Rashad AS, Mahfouz RZ. PMID: 42929801 [PubMed - as supplied by publisher]
	Efficacy and Safety of 5% Topical Caffeine Added to 0.025% Fluocinolone Acetonide Cream for Plaque Psoriasis: A Randomized Controlled Trial. Psoriasis (Auckl) Mamizadeh H, Herizchi Ghadim H, Pourasghary S. PMID: 42928804 [PubMed]
	Food-Derived Substances and Edible Chinese Medicinal Materials in Psoriasis Management: Potential, Evidence, and Perspectives-A Narrative Review. Clin Cosmet Investig Dermatol Ma X, Zheng S, Kai J, Wu X. PMID: 42928794 [PubMed]
	Management of scalp psoriasis: Updated treatment recommendations from a Delphi consensus of 53 dermatologists from AEDV Psoriasis Working Group. Actas Dermosifiliogr González Cantero Á, Ferrán M, Pérez Barrio S, Daudén E, Aubán Pariente J, Carrascosa JM, de la Cueva P. PMID: 42926054 [PubMed - as supplied by publisher]
	Lightweight interpretable support vector machine SERS (LiSVM-SERS) learning framework for serological diagnosis of psoriatic arthritis and biomarker identification. Spectrochim Acta A Mol Biomol Spectrosc Zhang H, Lin W, Pan H, Cao L, Wang Y, Sun H, Zhao Y, Jia Y, Yan Y. PMID: 42925688 [PubMed - as supplied by publisher]
	Gut microbiota-host immunity crosstalk in psoriasis: from dysbiosis to cutaneous inflammation. Front Immunol Zhang M, Zhang S, Ren X. PMID: 42921249 [PubMed - indexed for MEDLINE]
	Th17/Treg imbalance and clinical characteristics in psoriasis patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis. Front Immunol Dong S, Qiu Z, Zhao Z, Bao H, Liu X, Mu Z, Zhang J, Li H, Feng B, Cai L. PMID: 42920534 [PubMed - indexed for MEDLINE]
	Exercise, physical activity, and physical fitness in psoriasis and psoriatic arthritis: an umbrella review. Front Immunol Lyu Z, Ma J, Ma C, Tian X, Liu L, Zhang J, Gao Y. PMID: 42920485 [PubMed - indexed for MEDLINE]
	Psoriasis: Which therapy for which patient, updated, part II. Focus on special populations and chronic infections. J Am Acad Dermatol Karpoff K, Pasumarthi A, Lebwohl M. PMID: 42913858 [PubMed - as supplied by publisher]
	Overcoming the cutaneous barrier: Topical delivery platforms for targeted gene-based therapeutics in psoriasis. J Control Release Lin ZC, Lin CY, Chung YK, Alalaiwe A, Fang JY. PMID: 42913795 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28698

Page 1 of 1435



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy